Concert Pharmaceuticals Aktie
WKN DE: A1XEAC / ISIN: US2060221056
08.08.2017 13:27:32
|
Concert Pharma Q2 Net Loss Slightly Narrows
(RTTNews) - Concert Pharmaceuticals Inc. (CNCE) Tuesday announced net loss of $13.03 million for the second quarter, narrower than net loss of $13.44 million last year. On a per share basis, loss narrowed to $0.58 from $0.60 per share.
On average, 5 analysts polled by Thomson Reuters expected the company to record loss of $0.66 per share. Analysts estimates usually exclude special items.
Total revenue for the quarter fell to $15 thousand from $71 thousand last year. Wall Street expected the company to report revenue of $50K.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Concert Pharmaceuticals Incmehr Nachrichten
Keine Nachrichten verfügbar. |